Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Amryt Pharma plc

CIK 1783010Updated Nov 16, 2026

Securities
Historical securities (1)AMYT · NASDAQ · adr · closed Apr 12, 2023
Name history
Amryt Pharma Holdings Ltd · through Aug 8, 2019

AMYT price & chart

Provider market data
Historical security

This listing closed Apr 12, 2023. Live provider charts are shown only for current listings.

In the news

No coverage from other publishers is available.

Recent filings

  1. 15F-12B filing

    15F-12B · 2023-04-24 · 0001140361-23-019690

  2. EFFECT filing

    EFFECT · 2023-04-21 · 9999999995-23-001005

  3. EFFECT filing

    EFFECT · 2023-04-21 · 9999999995-23-001003

  4. EFFECT filing

    EFFECT · 2023-04-21 · 9999999995-23-000998

  5. POS AM filing

    POS AM · 2023-04-18 · 0001140361-23-018932

Show 5 more recent filings
  1. POS AM filing

    POS AM · 2023-04-18 · 0001140361-23-018930

  2. POS AM filing

    POS AM · 2023-04-18 · 0001140361-23-018928

  3. 6-K filing

    6-K · 2023-04-12 · 0001140361-23-018039

  4. 25-NSE filing

    25-NSE · 2023-04-12 · 0001354457-23-000262

  5. 6-K filing

    6-K · 2023-04-03 · 0001140361-23-015657

Financials

FY 2021 · USD
Revenue222,543,000USD · FY 2021
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

Net income— · FY 2021
Assets—USD · FY 2021
Cash— · FY 2021
Operating income-38,588,000USD · FY 2021
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

Diluted EPS0USD per share · FY 2021
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

Some figures are unavailable for this reporting year.

Balance-sheet figures are unavailable pending verification.

cash flow · annual statements
Line itemFY 2021FY 2020FY 2019
Cash flows from operating activities:
Profit or LossUSD1,000,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

-104,527,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

-62,998,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

Additional Financial Items
AdjustmentsForSharebasedPaymentsUSD8,341,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

4,729,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

841,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

GoodwillUSD56,688,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

As of 2021-12-31

19,131,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

As of 2020-12-31

19,131,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

As of 2019-12-31

InterestPaidClassifiedAsFinancingActivitiesUSD12,283,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

10,780,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

6,253,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD1,215,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

1,119,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

0
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD816,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

963,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

74,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2021FY 2020FY 2019
Cost of Goods and Services Sold———
Selling, General and Administrative ExpenseUSD91,995,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

76,673,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

35,498,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

Total RevenueUSD222,543,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

182,607,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

58,124,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

Additional Financial Items
BasicEarningsLossPerShareUSD per share0
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

——
DeferredTaxExpenseIncomeRecognisedInProfitOrLossUSD62,395,001
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

38,244,152
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

25,858,892
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

DilutedEarningsLossPerShareUSD per share0
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

——
EmployeeBenefitsExpenseUSD64,330,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

44,219,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

23,470,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ExpenseFromSharebasedPaymentTransactionsWithEmployeesUSD8,341,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

4,729,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

841,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsedUSD189,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

623,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

170,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ExpenseRelatingToVariableLeasePaymentsNotIncludedInMeasurementOfLeaseLiabilitiesUSD0
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

0
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

0
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

GrossProfitUSD116,424,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

63,578,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

19,391,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwillUSD0
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

0
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

4,670,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

IncomeTaxExpenseContinuingOperationsUSD-7,562,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

-1,332,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

-495,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

InterestExpenseOnLeaseLiabilitiesUSD558,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

335,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

17,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

OtherFinanceCostUSD27,906,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

19,569,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

4,759,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

PostemploymentBenefitExpenseDefinedBenefitPlansUSD1,643,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

1,213,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

769,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

PostemploymentBenefitExpenseDefinedContributionPlansUSD1,763,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

1,284,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

769,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ProfitLossBeforeTaxUSD-6,562,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

-105,859,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

-63,493,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ProfitLossFromOperatingActivitiesUSD-38,588,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

-46,459,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

-50,483,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

ResearchAndDevelopmentExpenseUSD37,729,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

27,618,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

15,827,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

RevenueFromInterestUSD5,000
Source

20-F · 2022-04-29 · 0001140361-22-016877

2021-01-01 to 2021-12-31

-87,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2020-01-01 to 2020-12-31

-92,000
Source

20-F · 2021-04-30 · 0001140361-21-015121

2019-01-01 to 2019-12-31

Lines labelled “Derived” are calculated from reported figures.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.